Here’s whether Elanco Animal Health Incorporated Common Stock (ELAN) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.10% over 10 days); RSI 47 — healthy momentum range; strong 1-year return of +69.6%; 3-month momentum positive (+9.5%). Currently 10.1% off its 52-week high. Score: +7/7.
ELAN is in a confirmed uptrend, trading above both its 50-day ($23.86) and 200-day ($23.31) moving averages. An RSI of 47.2 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +69.6% compares to +16.5% for SPY (beat the market by 53.1%).
$10,000 invested 1 year ago→ $16,957 today
vs. S&P 500 (SPY) — same period beat market by 53.1%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($23.31)
✓Above 50-day MA ($23.86)
✓RSI(14) neutral zone (30–70) — currently 47.2
✓Positive return (+69.6%)
!Within 10% of period high (−10.1%)
Period Range $24.91
$13.39$27.72
RSI (14) 47.2
0 · OversoldOverbought · 100
Key Metrics
Price$24.91
Period Return+69.6%
Period High$27.72
Period Low$13.39
Drawdown−10.1%
MA-50$23.86
MA-200$23.31
RSI (14)47.2
Avg Volume (30d)4.7M
vs. SPYbeat by 53.1%
Return Rank#151 of 999
Trend Signals
Price is above the 200-day moving average ($23.31)